SILINGARDI, PAOLA
 Distribuzione geografica
Continente #
NA - Nord America 2.089
AS - Asia 1.574
EU - Europa 1.531
AF - Africa 132
Continente sconosciuto - Info sul continente non disponibili 86
SA - Sud America 82
OC - Oceania 7
Totale 5.501
Nazione #
US - Stati Uniti d'America 2.069
VN - Vietnam 496
SG - Singapore 458
GB - Regno Unito 376
CN - Cina 337
IT - Italia 240
SE - Svezia 203
DE - Germania 160
UA - Ucraina 104
FR - Francia 92
HK - Hong Kong 83
RU - Federazione Russa 66
IN - India 61
CH - Svizzera 58
IE - Irlanda 56
BR - Brasile 50
NL - Olanda 41
FI - Finlandia 29
TG - Togo 29
JP - Giappone 28
ZA - Sudafrica 26
BG - Bulgaria 25
EE - Estonia 23
NG - Nigeria 22
SC - Seychelles 22
IR - Iran 19
KR - Corea 18
CI - Costa d'Avorio 17
BE - Belgio 14
CA - Canada 13
PH - Filippine 13
HR - Croazia 12
AR - Argentina 11
TH - Thailandia 10
BD - Bangladesh 9
PL - Polonia 9
TR - Turchia 8
TW - Taiwan 8
AU - Australia 7
ES - Italia 7
CL - Cile 5
CO - Colombia 5
ID - Indonesia 5
IQ - Iraq 5
EG - Egitto 4
GR - Grecia 3
MX - Messico 3
OM - Oman 3
PT - Portogallo 3
RS - Serbia 3
EC - Ecuador 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LT - Lituania 2
PE - Perù 2
PY - Paraguay 2
UG - Uganda 2
UY - Uruguay 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AO - Angola 1
AT - Austria 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BW - Botswana 1
CG - Congo 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
ET - Etiopia 1
GY - Guiana 1
HU - Ungheria 1
JM - Giamaica 1
KW - Kuwait 1
MR - Mauritania 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
PK - Pakistan 1
PR - Porto Rico 1
SA - Arabia Saudita 1
SN - Senegal 1
UZ - Uzbekistan 1
ZW - Zimbabwe 1
Totale 5.415
Città #
Singapore 330
Southend 330
Chandler 300
Ashburn 169
Santa Clara 168
Fairfield 98
Ho Chi Minh City 91
San Jose 91
Hanoi 83
Jacksonville 81
Hong Kong 77
Ann Arbor 76
Princeton 68
Wilmington 67
Bern 58
Dublin 56
Beijing 51
Woodbridge 50
Seattle 49
Dong Ket 45
Cambridge 44
Houston 37
Boardman 34
Lauterbourg 33
Padova 33
Nanjing 32
New York 32
Lomé 29
Los Angeles 29
Westminster 29
Helsinki 28
Sofia 25
Medford 23
Tokyo 22
Turin 22
Abeokuta 21
Berlin 21
Council Bluffs 19
Milan 19
Abidjan 17
Hefei 17
Dallas 14
San Diego 14
Falls Church 13
Haiphong 13
Hebei 13
Shenyang 13
Brussels 12
Saint Petersburg 11
The Dalles 11
Buffalo 10
Jinan 10
Mülheim 10
Tianjin 10
Da Nang 9
Frankfurt am Main 9
Bologna 8
Guangzhou 8
Hangzhou 8
Nanchang 8
Orem 8
Falkenstein 7
Imola 7
Mountain View 7
Rome 7
Toronto 7
Brooklyn 6
Can Tho 6
Changsha 6
Düsseldorf 6
Mahé 6
San Venanzo 6
Seoul 6
São Paulo 6
Zhengzhou 6
Atlanta 5
Hải Dương 5
Jiaxing 5
Paris 5
Redondo Beach 5
Shanghai 5
Thái Nguyên 5
Xi'an 5
Amsterdam 4
Catanzaro 4
Chicago 4
Dearborn 4
Des Moines 4
Genova 4
Harbin 4
London 4
Melbourne 4
Ningbo 4
Olalla 4
Phoenix 4
Redwood City 4
San Francisco 4
Trieste 4
Verona 4
Warsaw 4
Totale 3.313
Nome #
Valutazione degli effetti citotossici e trasformanti indotti da fibre ceramiche refrattarie e fibre policristalline nel modello in vitro BALB/c 3T3 319
BIOMARKER END-POINTS IN OCCUPATIONAL EXPOSURE TO ANTINEOPLASTIC DRUGS 253
Evaluation of in vitro toxicity and efficacy of ferutinin, a natural promising chemopreventive compound 241
EVALUATION OF AN INNOVATIVE RETINOID, RO 41-5253, AS A CHEMOPREVENTIVE AGENT. 234
BIOMARKERS IDENTIFICATION OF IONIZING RADIATION EXPOSURE IN BALB/c 3T3 CELLS 227
Assessment of polychlorinated biphenyls: prospects for a global approach 215
GENE-ENVIRONMENT INTERACTION: THE IMPORTANCE OF OMICS IN UNDERSTANDING THE EFFECT OF LOW-DOSE EXPOSURE 213
BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential 212
BIOMONITORING OF NURSES OCCUPATIONALLY EXPOSED TO ANTINEOPLASTIC DRUGS: THE IMEPA PROJECT 207
Different sensitivity of BALB/c 3T3 cell clones in the response to carcinogens 206
EFFECT OF YESSOTOXIN ON BALB/c 3T3 CELL TRANSFORMATION 206
Esposizione ad antiblastici negli ospedali: identificazione di marcatori precoci di danno biologico. 198
A cDNA-microarray analysis of camptothecin resistance in glioblastoma cell lines 196
Angiopoietin-2 expression in B-cell chronic lymphocytic leukemia: association with clinical outcome and immunoglobulin heavy-chain mutational status 194
Gene expression changes in medical workers exposed to radiation 192
IN VITRO EVALUATION OF TOXICITY AND TRANSFORMING ACTIVITY OF MAN MADE FIBERS 188
In vitro endpoints to profile risks associated with waste incineration 186
GENE EXPRESSION PROFILING TO MONITOR IONIZING RADIATION EXPOSURE 179
The in vitro BALB/c 3T3 cell transformation assay to profile the carcinogenic activity of environmental mixtures 166
THE BALB/c 3T3 CELL TRANSFORMATION ASSAY TO ASSESS THE CARCINOGENIC ACTIVITY OF CHEMICALS 163
The in vitro BALB/c 3T3 cell transformation assay to screen the anti-transforming activity of chemical compounds 155
OLIGONUCLEOTIDE MICROARRAY ANALYSIS OF LOW-DOSE IONIZING RADIATION EXPOSURE 155
EVALUATION OF THE RESPONSE TO LOW DOSE IONIZING RADIATION BY GENE EXPRESSION PROFILE 150
GENE EXPRESSION PROFILING IN B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA REVEALS DIFFERENTIAL EXPRESSION LEVELS OF EDAG AND ANGIOPOIETIN-2 GENES BETWEEN UNMUTATED AND MUTATED PATIENTS 149
IN VITRO MODELS FOR THE PRE-CLINICAL EVALUATION OF PROMISING CHEMOPREVENTIVE AND THERAPEUTIC MOLECULES 148
Gene expression profiles as endpoints in hazard identification of environmental exposure 143
OLIGONUCLEOTIDE MICROARRAY TIME-SERIES ANALYSIS TO EVALUATE CAMPTOTHECIN EFFECTS: A GLIOBLASTOMA MODEL 139
In vitro models to assess toxicity and efficacy of resveratrol, a natural promising tumor chemopreventive agent. 134
IN VITRO ENDPOINTS TO PROFILE RISKS AND BENEFITS ASSOCIATED TO ENDOCRINE ACTIVE COMPOUNDS. 133
Totale 5.501
Categoria #
all - tutte 13.252
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.252


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022552 0 19 18 28 73 56 23 27 13 43 104 148
2022/2023909 119 165 73 126 41 75 30 36 87 8 83 66
2023/2024165 11 26 6 8 12 41 4 3 5 21 15 13
2024/2025685 49 79 44 62 206 58 19 1 3 62 28 74
2025/20261.659 60 85 101 103 247 136 185 30 349 143 193 27
2026/202745 31 14 0 0 0 0 0 0 0 0 0 0
Totale 5.501